When to See a Doctor About Snoring or Suspected Sleep Apnea

Almost everyone snores once in a while, and most of the time it's harmless. But when snoring comes with breathing pauses, gasping, or a daytime fog that coffee can't fix, it may be signaling a treatable medical condition — obstructive sleep apnea (OSA). Knowing which symptoms are simple nuisances and which are genuine red flags helps you decide when it's worth getting evaluated, and what that process actually looks like.

This is data education, not a substitute for a medical exam. The goal here is to help you recognize when to start a conversation with a clinician — not to self-diagnose.

Snoring vs sleep apnea

Snoring is the sound of air squeezing past partially relaxed tissues in your throat. On its own, in an otherwise healthy person, it's usually a social problem more than a medical one.

Sleep apnea is different in kind, not just degree. In obstructive sleep apnea, the airway doesn't just narrow — it repeatedly collapses, briefly cutting off airflow. Each event ends with a micro-arousal as your brain nudges your body to resume breathing, often dozens of times an hour, all night, without you remembering any of it. The result is fragmented sleep and repeated dips in blood oxygen.

Here's the catch: snoring and apnea can sound nearly identical to a bed partner at first. The features that distinguish them are subtle.

If you want a deeper primer on the condition itself, our Understanding Sleep Apnea pillar walks through types, severity, and how it's measured, and What Is Sleep Apnea? explains the AHI scale that clinicians use.

Red-flag symptoms that warrant evaluation

You don't need every symptom to justify a visit. Any one of the following is a reasonable reason to talk to a clinician — and a combination raises the priority.

The classic warning signs are:

• Loud snoring punctuated by silent pauses — the snore stops, the chest may still strain, then breathing restarts.
• Witnessed gasping, snorting, or choking during sleep, usually noticed by a bed partner.
• Persistent daytime fatigue, sleepiness, or irritability — nodding off while reading, watching TV, in meetings, or (most dangerously) while driving.

Other clues worth mentioning to a clinician include:

• Waking with a dry mouth, sore throat, or morning headaches
• Frequent nighttime trips to the bathroom
• Trouble concentrating, memory lapses, or low mood
• Waking with a racing heart or shortness of breath
• High blood pressure that's hard to control

That last point matters more than people realize. OSA is strongly associated with — and in several cases an independent risk factor for — high blood pressure, coronary artery disease, atrial fibrillation, heart failure, pulmonary hypertension, and stroke, and it's also linked to type 2 diabetes. Left untreated, OSA lowers quality of life and raises cardiovascular, stroke, and overall mortality risk. The 2021 American Heart Association Scientific Statement specifically recommends sleep apnea testing in people with resistant or poorly controlled hypertension, pulmonary hypertension, and recurrent atrial fibrillation after cardioversion or ablation. Our guides on untreated sleep apnea risks and the heart and cardiovascular connection go deeper on why these numbers matter.

When in doubt, get evaluated. The downside of a normal result is reassurance; the downside of an undiagnosed case can compound for years.

What to expect at the appointment

Evaluation should be physician-directed — meaning a clinician, not a gadget or a quiz, decides what testing (if any) you need and interprets the results. You can start with your primary care doctor, who may refer you to a sleep specialist, or go directly to a sleep clinic if your insurance allows.

A first visit usually covers:

1. Your symptom history — snoring, pauses, daytime sleepiness, and how long it's been going on. Bringing a bed partner, or notes from one, is genuinely useful, since you can't observe your own sleep.
2. A sleepiness questionnaire — tools like the Epworth Sleepiness Scale and STOP-Bang help quantify risk.
3. A focused physical exam — neck circumference, jaw and airway anatomy, nasal passages, blood pressure, and weight.
4. Risk-factor review — family history, alcohol use, sedatives, and existing heart, lung, or metabolic conditions.

It helps to walk in prepared. Jot down when your symptoms started, anything your partner has noticed, your current medications, and a few questions of your own. If you've used any consumer sleep tracker, mention it — but understand that a wearable's "sleep score" is not a diagnosis. To see how risk factors stack up, Who Gets Sleep Apnea? is a useful companion read.

The testing pathway

If your evaluation suggests sleep apnea, the next step is an objective sleep study. There are two main types, and which one you get is a clinical decision, not a preference.

Home sleep apnea test (HSAT). A small kit you wear at home for a night or two, typically recording airflow, breathing effort, oxygen levels, and heart rate. Per the AASM Clinical Practice Guideline for Diagnostic Testing for Adult OSA (Kapur et al., 2017), an HSAT with a technically adequate device may be used to diagnose OSA in uncomplicated adults who show signs and symptoms indicating an increased risk of moderate-to-severe OSA.

In-lab polysomnography (PSG). An overnight study at a sleep center with full sensors, including brain-wave (EEG) monitoring that a home test can't capture. The same guideline recommends in-lab PSG rather than a home test for people with:

• Significant heart or lung disease
• Possible respiratory muscle weakness from a neuromuscular condition
• Awake hypoventilation or suspected sleep-related hypoventilation
• Chronic opioid use
• A history of stroke
• Severe insomnia

PSG (not a home test) is also required to diagnose non-obstructive sleep-disordered breathing such as central sleep apnea — where the issue is the brain's breathing drive rather than a blocked airway — and hypoventilation. And if a home test comes back negative, inconclusive, or technically inadequate, the guideline says you should move on to in-lab PSG rather than assuming you're in the clear.

Our in-lab PSG vs home test guide breaks down each option in more detail, including how the study is used to set your therapy pressure if you're diagnosed.

A study yields your AHI (apnea-hypopnea index) — the average number of breathing events per hour — which determines whether you have OSA and how severe it is. One nuance worth knowing: how "hypopneas" (partial reductions in airflow) get scored varies. The AASM's recommended rule (1A) counts an event with a 3% oxygen drop or an arousal, while an acceptable alternative rule (1B), often used for insurance, requires a 4% drop. The same night of sleep can produce a different AHI depending on which rule is applied, which is why interpretation belongs with a clinician.

After diagnosis — tracking your therapy

If you're diagnosed and prescribed CPAP (continuous positive airway pressure), the work isn't over — it's just changing shape. CPAP splints the airway open and reliably treats obstructive events, and most people start feeling sharper within days to weeks. But "I'm wearing it" and "it's working well" are two different questions, and the only way to answer the second is with data.

A few realities to keep in mind:

• Single-night numbers are noise; trends over weeks are what matter. One rough night doesn't mean failure, and one perfect night doesn't mean you're done.
• Mask leak can quietly distort your AHI. A large leak can cause your machine to under-report events, so a "good" number isn't trustworthy if leaks are high.
• Central events can emerge on CPAP. A rise in central (clear-airway) events early in therapy can indicate treatment-emergent central sleep apnea (TECSA), which appears in roughly 5–15% of PAP titrations and resolves on its own in about 60–80% of cases within weeks to a few months of continued CPAP. Persistent cases should be evaluated by your clinician — never raise your own pressure to chase them.

This is where having your own readable data becomes powerful. Once you're diagnosed and start CPAP, SomniCharts becomes your ongoing check that therapy is actually working — in plain language, no OSCAR required. It imports data from ResMed, Philips Respironics (including the DreamStation 2, whose SD-card data is encrypted and unreadable by most third-party tools), and Löwenstein prisma machines, then explains your residual AHI, leak rate, and pressure trends automatically so you can have an informed conversation with your provider.

For the treatment target, a residual AHI below 5 events per hour is the widely used benchmark for effective CPAP therapy — the AASM defines an "optimal" titration as fewer than 5 per hour, which is also the normal, non-apneic range. Some clinicians aim lower (e.g., under 1–2) when it's comfortably achievable, but there's no formal guideline establishing a "below 2" standard, and your goal is individualized with your provider. To learn how to read the numbers yourself, start with How to Read Your CPAP Data and What Is a Good AHI on CPAP?.

Remember the recurring theme: getting diagnosed is a milestone, not a finish line. The people who do best are the ones who keep an eye on their trends and bring real data — not guesses — to each clinic visit.